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Surgical dogma has a legitimate role in preventing us from performingoperations we should not perform. It defines, often helpfully, the rulesof surgical engagement. Break the rules, and your patient may suffer.One example of dogma is that lobectomy with mediastinal lymphnode dissection should be performed for all clinical stage I non–smallcell lung cancers.1 A strict rule such as this places us in a safe harbor,
obviating any worry about variables like tumor biology, presence or absence of
nodal disease, and pulmonary resection margins. These elements of surgical deci-
sion making are rendered moot. After all, the prescribed operation automatically
covers all the bases.
At the other extreme, some surgeons may defy dogma and, instead, do what is
easier. For instance, just go ahead with a VATS (video-assisted thoracoscopic
surgery) wedge resection without lymph node sampling, especially after negative
mediastinoscopic results. From this vantage point, intralobar and interlobar lymph
node removal may be unimportant for survival. After all, tumor biology probably
plays the primary role in prognosis, so simple tumor excision should suffice.
Thankfully, an alternative middle road may be developing in thoracic surgical
oncology, as it has in other areas of surgical oncology such as breast cancer and
melanoma. In those two areas, less surgery has become more common. The reasons
include (1) ability to assess resection margins intraoperatively for tumor presence,
(2) technical advances such as sentinel node biopsy with immunohistochemical and
polymerase chain reaction detection of occult micrometastases, and (3) scientific
evidence that survival is equivalent to that of more radical procedures.
In the January 2003 issue of the Journal, Higashiyama and associates2 showed us
how to be sure that the “margins are negative” intraoperatively, through a unique
method of washing, in 200 mL of saline solution, the staple cartridges (if staplers are
used); the wedge specimen itself (if an Nd:YAG laser or electric scissors are used);
or both (if both techniques are used). Then, centrifugal plating with a Cytospin
device (Thermo Electron Corporation, Waltham, Mass) is performed, with exami-
nation of the stained slides for evidence of tumor cells. The entire process takes only
20 to 25 minutes.
In their study, of 115 lesions resected (110 via open thoracotomy with wide
wedge resection or segmentectomy), 11 (10%) had positive surgical resection
margins. Margin positivity correlated with tumor size: less than 1.0 cm, 3% (1/35);
1.1 to 2.0 cm, 8% (3/36); 2.1 to 3.0 cm, 14% (4/28); and more than 3.1 cm, 23%
(3/13). Margin positivity rates did not differ by resection technique. Of the 11
patients with positive margins, 7 could not undergo further surgical resection
because of limited physiologic reserve; of these 7 patients, 3 experienced recurrence
in their “surgical resection margin.” Most noteworthy was that the finding of a
negative margin was highly predictive: 0 margin recurrences in 101 resected
specimens.
I have never found the rationale for segmentectomy or wedge resection via
thoracotomy in a patient with sufficient pulmonary reserve for lobectomy to be
compelling. The gain in preservation of pulmonary function (as compared with
lobectomy) is likely to be so small that it does not warrant the potential risks of a
higher local recurrence rate or of death from cancer.3 However, a limited VATS
resection, avoiding the immediate morbidity of a thoracotomy, has appeal—if
proper cancer staging can be accomplished and if the surgeon is sure that the
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resection is complete, that is, that the “margins are nega-
tive.” In a protocol setting, I could envision performing a
limited VATS wedge resection for stage IA tumors as
primary therapy in a patient physiologically able to undergo
lobectomy, by using thoracoscopic sentinel node sampling4
combined with the margin testing technique of Higashiyama
and colleagues.2
However, until definitive data are available, I continue to
stay in the safe harbor of lobectomy and nodal resection.
Before venturing from this safe harbor, either intention-
ally in a patient with good cardiopulmonary reserve or as a
compromise operation in a patient unable to tolerate lobec-
tomy, we must first protect the patient. Higashiyama and
associates2 have now provided us with one piece of the
limited resection safety puzzle with their technique of mar-
gin testing. Until now, our ability to assess margins by
frozen section has been severely limited by the use of
staples or by the difficulty of accurately dissecting and
freezing an open pulmonary margin. The technique pro-
vided by Higashiyama’s group2 should be adopted and used
by all surgeons performing a limited resection, regardless of
the indication.
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